Coronavirus Disease 2019 (COVID-19) Impact on Pharmaceutical Trade and Supply Chain – Q3 2020 Survey
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
This report provides an update on the assessment of how the pharmaceutical industry perceives the supply chain disruption caused by the COVID-19 pandemic, including the challenges associated with clinical trials, logistics, API and finished dose manufacturing.
Since the first case was diagnosed in Wuhan, China, in December 2019, COVID-19 cases have continued to rise rapidly across the globe.
Scope
GlobalData’s “Pharmaceutical Trade and Supply Chain Survey, Q3 2020 – Coronavirus Disease 2019 (COVID-19) Impact” provides in-house analyst expertise on the results of a 5 minute survey of 75 GlobalData Pharma clients and prospects, which was fielded from July 7, 2020 to July 30, 2020.
Reasons to Buy
Objectives included:
Benchmark companies’ primary concerns
Determine the impact of COVID-19 to date on supply chains
Assess companies’ strategic future plans
Track changes to corporate strategy and attitudes
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.